Research on SIRT1 in AKI has been extensive since 2010, with studies showing that overexpressing SIRT1 in the kidneys significantly reduces cisplatin-induced AKI [65], and pharmacological activation of SIRT1 also mitigates cisplatin-induced AKI [66]. The gene discussed is SIRT1; the disease is acute kidney injury.